1-800-729-1232

glyphosate

Bayer Seeking Legal Protection from Lawsuits Alleging Roundup Causes Cancer

Product Liability / April 16, 2024 / 4 minutes of reading / By / , , , , , , , , , , , ,

Bayer, the chemical giant behind the popular weedkiller Roundup, has faced significant legal battles and hefty settlements over claims that the product causes cancer. Seeking to protect itself from further liability, Bayer has been lobbying lawmakers in several states to pass bills providing legal protection from Roundup cancer claims.  Bills introduced this year in Iowa, …

Bayer Seeking Legal Protection from Lawsuits Alleging Roundup Causes Cancer Read More »

Roundup Weed Killer: Bayer’s Search for a Glyphosate Replacement

Product Liability / March 22, 2024 / 3 minutes of reading / By / , , , , , , , , , , , , ,

In recent years, Roundup weed killer, manufactured by Bayer, has faced significant controversy due to its active ingredient, glyphosate. The herbicide has been linked to an increased risk of non-Hodgkin’s lymphoma, leading to an onslaught of lawsuits against the company. Bayer officials have now revealed that they are in the process of testing a potential …

Roundup Weed Killer: Bayer’s Search for a Glyphosate Replacement Read More »

Bayer Considers Controversial Bankruptcy Scheme to Settle Roundup Lawsuits

Product Liability / March 22, 2024 / 4 minutes of reading / By / , , , , , , , , , , , , , , ,

The controversy surrounding Bayer AG and its Roundup weedkiller continues to escalate as the company faces massive verdicts in non-Hodgkins lymphoma lawsuits. With a wave of additional trials set to take place throughout 2024, Bayer is reportedly considering a controversial bankruptcy scheme known as the “Texas two-step” to force settlements through the U.S. bankruptcy system. …

Bayer Considers Controversial Bankruptcy Scheme to Settle Roundup Lawsuits Read More »

Philadelphia Jury Delivers $2.25 Billion Verdict in Latest Roundup Trial

Product Liability / February 1, 2024 / 3 minutes of reading / By / , , , , , , , , , ,

In a landmark verdict, a Philadelphia jury has awarded a staggering $2.25 billion in damages in a trial involving the popular weed killer Roundup. The plaintiff, John McKivison, a resident of Lycoming County, Pennsylvania, claimed that his prolonged exposure to Roundup caused him to develop non-Hodgkin’s lymphoma. This verdict marks the third significant ruling against …

Philadelphia Jury Delivers $2.25 Billion Verdict in Latest Roundup Trial Read More »

Roundup Weed Killer Verdict: $3.5 Million Awarded in Latest Trial

Product Liability / December 10, 2023 / 4 minutes of reading / By / , , , , , , ,

Roundup, the popular weed killer manufactured by Monsanto and its parent company Bayer, has been at the center of numerous lawsuits alleging that exposure to the product can cause cancer, particularly non-Hodgkin’s lymphoma. In the most recent trial, decided on December 1, 2023, a Philadelphia jury awarded $3.5 million to a woman who claimed Roundup …

Roundup Weed Killer Verdict: $3.5 Million Awarded in Latest Trial Read More »

Latest Roundup Trial Ends in Staggering $1.5 Billion Verdict over Cancer Claims

Product Liability / November 21, 2023 / 5 minutes of reading / By / , , , , , , ,

In a recent landmark decision, Bayer AG’s subsidiary, Monsanto, was ordered by a Missouri jury to pay a staggering $1.56 billion in damages in the latest Roundup trial. The verdict, one of the largest in the five-year litigation over Roundup, comes as a major blow to the German pharmaceutical and chemical company, raising new questions …

Latest Roundup Trial Ends in Staggering $1.5 Billion Verdict over Cancer Claims Read More »

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma

Product Liability / November 6, 2023 / 5 minutes of reading / By / , , , , , , , , ,

Earlier this week, pharmaceutical and biotechnology giant Bayer was ordered to pay $332 million in damages to a man who claimed his cancer was caused by exposure to the company’s Roundup weed killer. The verdict includes $7 million in compensatory damages and $325 million in punitive damages designed to punish the company for failing to …

California Jury Awards $332 Million in Roundup Trial Over Non-Hodgkin’s Lymphoma Read More »

Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial

Product Liability / November 6, 2023 / 4 minutes of reading / By / , , , , , , , ,

In a significant blow to pharmaceutical giant Bayer AG, a Philadelphia jury on Friday ordered the company to pay $175 million in damages in a trial involving their widely-used weed killer, Roundup. The plaintiff, retired restaurant owner Ernest Caranci, claimed that his prolonged exposure to Roundup caused him to develop non-Hodgkin’s lymphoma. This and a …

Roundup Verdict: Bayer Ordered to Pay $175 Million in Latest Cancer Trial Read More »

Bayer Increases Payout for Future Roundup Cancer Claims to $2 Billion

Personal Injury / November 3, 2023 / 4 minutes of reading / By / , , , , ,

Bayer, the maker of Roundup weed killer, has agreed to increase the compensation the company will pay to resolve future non-Hodgkin’s lymphoma claims to $2 billion, after announcing an initial proposal last year that would have set aside $1.25 billion for future cases alleging that Roundup causes cancer. If you or someone you love has …

Bayer Increases Payout for Future Roundup Cancer Claims to $2 Billion Read More »

Bayer Agrees to Pay $39.5 Million in Class Action Lawsuit Over Misleading Roundup Claims

Personal Injury / November 21, 2023 / 4 minutes of reading / By / , , , , , ,

Bayer AG has agreed to pay $39.5 million to resolve allegations that its Monsanto subsidiary made false and misleading claims in advertisements about Roundup and the potential health risks the controversial weed killer may pose for humans and animals. As part of the settlement agreement, the company will remove from the Roundup Weed and Grass …

Bayer Agrees to Pay $39.5 Million in Class Action Lawsuit Over Misleading Roundup Claims Read More »

Scroll to Top